Click to rate this post!
[Total: 0 Your Rating: 0]You must sign in to vote
The latest deals available for investment are out! We’ve created a list so you can see all these new startups in one easy place.
We’ve also highlighted three exciting deals below. These are not KingsCrowd staff picks, so be sure to check out their analytics page to get more information if you’re interested in one of them.
Footcoin, an alternative investment platform, is raising funds on FundMe. The platform gives investors access to investments in sports, portfolio tracking, and secondary market trading. Currently, the investment platform has 12 players from a team in Portugal.
Carmo Israel Rolim founded Footcoin in 2019. The current crowdfunding campaign has a minimum raise of $25,000 and a maximum raise of $1,070,000. The funds will be used for marketing, research and development, equipment purchases, technology development, and expenses with current players. Footcoin is led by a team of experts and advisors with decades of experience in discovering and training football talents. The company also has sports control over the team from Portugal and a relationship network in Brazil.
Vestigo, with a valuation cap of $8 million, is raising crowdfunding on Wefunder. The application inspires new mindsets through adventure. It helps teams solve their problems and build connections through VR adventure experiences.
Marshall Mosher and Daniel McBrayer founded Vestigo in 2015. The proceeds of the current crowdfunding round, with a minimum raise of $50,000 and a maximum raise of $1,070,000, will be used towards hiring new developers, project managers, and other employees, expanding the VR headset inventory, and paying salaries. Vestigo is working the best during the COVID pandemic when the need for virtual team building is at its peak. The current clients of the company include Microsoft, Home Depot, EY, and AT&T, among others.
20/20 GeneSystems, with a pre-money valuation of $38.5 million, is raising funds on StartEngine through Reg A+ crowdfunding. It is a diagnostics company with a successful track record in cancer detection with its AI-powered multi-cancer blood test, OneTest. The company has recently launched CoronaCheck, its FDA authorized antibody lab test for COVID-19 antibodies.
20/20 GeneSystems was founded by Jonathan Cohen in 2000. The current round of funding has a round size of $14,700,000. The proceeds will be used for sales and marketing, research and development, intellectual property development and protection, and cybersecurity and patient privacy protections. 20/20 GeneSystems has already sold over 70,000 COVID-19 antibody tests since its launch in March 2020, and year-over-year revenues have grown by over 600%.